CHICAGO, October 22, 2026 – For decades, doctors and those who speak on behalf of medicine have been expressing their frustrations regarding a gap in clinical science where illnesses that affect women more than men do not receive sufficient attention and research funding, and suffer from late diagnoses.
This has finally led to an official breakthrough on October 19, 2026.
During a White House ceremony, President Donald Trump signed an executive order creating a special division for Women’s Health in the NIH along with a White House Women’s Health Task Force. Championed by First Lady Melania Trump, who called the initiative setting “a new standard for women’s health in America,” the executive action aims to address longstanding disparities across biomedical research. U.S. Department of Health and Human Services press release reinforced that scientific studies not taking into account female physiology lack the clinical guidance necessary for physicians.
And this matters because the historical gap isn’t just an abstract policy debate—it carries a high physical cost.
Take endometriosis, for example. This painful condition affects millions of women across the world, but its diagnosis can take up to seven years because of disorganized research and dependent diagnostic criteria. Giving priority to such conditions through research is imperative in order to reform clinical trials.
Under this directive, the new division of the NIH needs to be officially set up in 90 days in order to facilitate gold-standard scientific research and to include sex as a biological variable in clinical trials. NIH Director Jay Bhattacharya noted that the division will help address these “lingering evidence gaps and bring scientific discoveries closer to patients” across the country. At the same time, the task force will organize federal resources for tracking outcomes from early adolescence through healthy ageing, led by the co-chair of HHS. The media noted that the new order aimed at using scientific breakthroughs and making clinical treatments available.
The policy follows up on the creation of the Office of Research on Women’s Health of NIH, which was first established back in 1990. With such bodies being placed within the realm of federal regulation, the directive forms a permanent federal body.
Nonetheless, there are policy analysts and health economists who argue that structural changes alone should be accompanied by actual grant allocation to be effective. There is concern regarding whether Congress will provide enough money in coming budget cycles and whether the division will be able to deal with the institutional resistance from grant-making agencies in the federal government.
Regardless of these challenges, the new executive order is a clear step towards making things better for many people who have suffered for years in the cold medical system. This is because the executive order makes public health policy recognize the reality of female physiology in its priority list.
